Phase 1 N=92 Memory & Conditioning Under Anesthesia
Anesthesia · Pain
Primary: Explicit Memory Performance — 1.16; .51; 1.04; .98 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=9 Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
Acral Lentiginous Melanoma
Primary: Overall Response Rate (ORR) — 1 participants
Phase 4 N=45 A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
Hemophilia A
Primary: Annualized Bleeding Rate (ABR) of All Bleeding Episodes During Prophylaxis Treatment in Part A — 1.86; 3.38 Bleed per year
N/A N=7 Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS
Multiple Sclerosis
Primary: Expanded Disability Status Score — 6.8 score on a scale
N/A N=8 Social Work Assistance and Stipends for Housing (SASH)
Opioid-Related Disorders · Housing Problems
Primary: Methadone Doses — 4.58 percent of missed doses
N/A N=25 Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
Primary: Hyperglycemia — 21.5; 33.3; 9.3; 11.7 Percent of Time (%)
Phase 2 N=30 A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
Acute-graft-versus-host Disease · aGVHD · GVHD
Primary: Number of Treatment Emergent Adverse Events — 4; 17; 9 Participants
N/A N=72 Introvision for Migraine and Headaches
Migraine · Chronic Migraine
Primary: Number of Headache Days Per Month — 10.6; 10.9 days per month — p=0.63
N/A N=314 Evaluation of PRYSHM for LGBTQIA2S+ Youth
Dating Violence · Alcohol Drinking
Primary: Intimate Partner Violence Perpetration at Week 21 — 5.79; 4.46 score on a scale
Phase 4 N=8 Impact of Erythropoietin on Hematological Adaptations and Physical Performance
Exercise-Induced Anemia · Physical Performance
Primary: Concentration of Hemoglobin — 1.46 g/dL
N/A N=8 Telehealth-Clinical Advocacy Project
Substance Use
Primary: Percent of Participants Who Received One or More Referrals During the 12-week Intervention. — 4 Participants
N/A N=598 Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
Atrial Fibrillation
Primary: Number of Patients With Freedom From AF, OAC and AAD Use — 257; 185; 208; 118 Participants
N/A N=125 Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials
Patient Participation · Pediatric ALL
Primary: Participants' Decision to Enroll in the CHOP Pediatric Clinical Trials Registry — 29; 30; 34; 32 Participants — p=<0.001
Phase 3 N=20 Effect of Ensifentrine Treatment on CAT Score
COPD
Primary: The Proportion of CAT Score Responders in the Full Analysis Set at Week 12 — 12 Participants
N/A N=1,036,294 A Study to Learn More About the Menopausal Hormone Therapies in Korea
Menopause · Bone Demineralization
Primary: Number of Women Who Visited Hospitals for Menopausal Symptoms Distributed Per Year — 786616; 787425; 791890; 818749 Participants